Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form
Everything about lung cancer is here.
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form
According to a new study led by researchers at NYU Grossman School of Medicine and its Laura and Isaac Perlmutter
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve